Amy Beth Vanduyn Sells 687 Shares of Phreesia (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR) SVP Amy Beth Vanduyn sold 687 shares of the stock in a transaction on Thursday, January 15th. The shares were sold at an average price of $16.38, for a total value of $11,253.06. Following the transaction, the senior vice president directly owned 159,551 shares in the company, valued at $2,613,445.38. The trade was a 0.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Amy Beth Vanduyn also recently made the following trade(s):

• On Friday, January 16th, Amy Beth Vanduyn sold 2,202 shares of Phreesia stock. The shares were sold at an average price of $16.36, for a total value of $36,024.72.
• On Thursday, January 8th, Amy Beth Vanduyn sold 2,602 shares of Phreesia stock. The shares were sold at an average price of $17.01, for a total value of $44,260.02.

Phreesia Stock Performance

Shares of Phreesia stock traded down $0.63 during trading hours on Tuesday, reaching $15.76. 888,246 shares of the stock traded hands, compared to its average volume of 1,011,187. Phreesia, Inc. has a one year low of $15.41 and a one year high of $32.76. The firm has a market capitalization of $950.23 million, a price-to-earnings ratio of -157.59 and a beta of 0.61. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average price of $18.24 and a 200 day moving average price of $23.18.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.11. The firm had revenue of $120.33 million for the quarter, compared to analysts’ expectations of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The business’s quarterly revenue was up 12.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.25) EPS. On average, equities research analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Phreesia

Several large investors have recently made changes to their positions in the business. Squarepoint Ops LLC boosted its stake in shares of Phreesia by 243.6% in the second quarter. Squarepoint Ops LLC now owns 100,922 shares of the company’s stock worth $2,872,000 after acquiring an additional 71,553 shares during the period. Farther Finance Advisors LLC grew its holdings in Phreesia by 9,375.0% during the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after buying an additional 3,000 shares in the last quarter. Arcadia Investment Management Corp MI grew its holdings in Phreesia by 22.3% during the 2nd quarter. Arcadia Investment Management Corp MI now owns 113,470 shares of the company’s stock valued at $3,229,000 after buying an additional 20,700 shares in the last quarter. Acadian Asset Management LLC raised its position in shares of Phreesia by 61.6% during the second quarter. Acadian Asset Management LLC now owns 364,194 shares of the company’s stock valued at $10,357,000 after buying an additional 138,877 shares during the last quarter. Finally, Boston Partners lifted its holdings in shares of Phreesia by 165.1% in the second quarter. Boston Partners now owns 130,060 shares of the company’s stock worth $3,702,000 after buying an additional 81,006 shares in the last quarter. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

PHR has been the subject of a number of recent research reports. Needham & Company LLC reissued a “buy” rating and set a $35.00 price objective on shares of Phreesia in a research report on Monday, December 8th. Mizuho lowered their target price on Phreesia from $36.00 to $28.00 and set an “outperform” rating on the stock in a research report on Wednesday, December 10th. Canaccord Genuity Group reduced their price target on Phreesia from $38.00 to $33.00 and set a “buy” rating for the company in a research report on Tuesday, December 9th. Royal Bank Of Canada assumed coverage on Phreesia in a research note on Friday, January 9th. They issued a “moderate buy” rating and a $26.00 price objective on the stock. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. Seventeen investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $30.06.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.